Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on Izokibep for Improving Symptoms in Patients with Active Psoriatic Arthritis
BulgariaStudy on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis
BulgariaStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
BulgariaStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
BulgariaStudy on the Long-term Safety and Effectiveness of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
GermanyStudy on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis
BelgiumStudy on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis
BulgariaStudy of Lebrikizumab and Topical Corticosteroids for Children and Teens with Moderate-to-Severe Atopic Dermatitis
CzechiaStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
AustriaStudy on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
BelgiumStudy of Oral NX-13 for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effectiveness and Safety of DC-806 for Adults with Moderate to Severe Plaque Psoriasis
CzechiaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
